Id |
Subject |
Object |
Predicate |
Lexical cue |
TextSentencer_T1 |
0-101 |
Sentence |
denotes |
Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. |
TextSentencer_T2 |
102-112 |
Sentence |
denotes |
OBJECTIVE: |
TextSentencer_T3 |
113-217 |
Sentence |
denotes |
To delineate the clinical characteristics of patients with coronavirus disease 2019 (covid-19) who died. |
TextSentencer_T4 |
218-225 |
Sentence |
denotes |
DESIGN: |
TextSentencer_T5 |
226-252 |
Sentence |
denotes |
Retrospective case series. |
TextSentencer_T6 |
253-261 |
Sentence |
denotes |
SETTING: |
TextSentencer_T7 |
262-294 |
Sentence |
denotes |
Tongji Hospital in Wuhan, China. |
TextSentencer_T8 |
295-308 |
Sentence |
denotes |
PARTICIPANTS: |
TextSentencer_T9 |
309-419 |
Sentence |
denotes |
Among a cohort of 799 patients, 113 who died and 161 who recovered with a diagnosis of covid-19 were analysed. |
TextSentencer_T10 |
420-463 |
Sentence |
denotes |
Data were collected until 28 February 2020. |
TextSentencer_T11 |
464-486 |
Sentence |
denotes |
MAIN OUTCOME MEASURES: |
TextSentencer_T12 |
487-609 |
Sentence |
denotes |
Clinical characteristics and laboratory findings were obtained from electronic medical records with data collection forms. |
TextSentencer_T13 |
610-618 |
Sentence |
denotes |
RESULTS: |
TextSentencer_T14 |
619-725 |
Sentence |
denotes |
The median age of deceased patients (68 years) was significantly older than recovered patients (51 years). |
TextSentencer_T15 |
726-824 |
Sentence |
denotes |
Male sex was more predominant in deceased patients (83; 73%) than in recovered patients (88; 55%). |
TextSentencer_T16 |
825-998 |
Sentence |
denotes |
Chronic hypertension and other cardiovascular comorbidities were more frequent among deceased patients (54 (48%) and 16 (14%)) than recovered patients (39 (24%) and 7 (4%)). |
TextSentencer_T17 |
999-1189 |
Sentence |
denotes |
Dyspnoea, chest tightness, and disorder of consciousness were more common in deceased patients (70 (62%), 55 (49%), and 25 (22%)) than in recovered patients (50 (31%), 48 (30%), and 1 (1%)). |
TextSentencer_T18 |
1190-1299 |
Sentence |
denotes |
The median time from disease onset to death in deceased patients was 16 (interquartile range 12.0-20.0) days. |
TextSentencer_T19 |
1300-1448 |
Sentence |
denotes |
Leukocytosis was present in 56 (50%) patients who died and 6 (4%) who recovered, and lymphopenia was present in 103 (91%) and 76 (47%) respectively. |
TextSentencer_T20 |
1449-1716 |
Sentence |
denotes |
Concentrations of alanine aminotransferase, aspartate aminotransferase, creatinine, creatine kinase, lactate dehydrogenase, cardiac troponin I, N-terminal pro-brain natriuretic peptide, and D-dimer were markedly higher in deceased patients than in recovered patients. |
TextSentencer_T21 |
1717-2083 |
Sentence |
denotes |
Common complications observed more frequently in deceased patients included acute respiratory distress syndrome (113; 100%), type I respiratory failure (18/35; 51%), sepsis (113; 100%), acute cardiac injury (72/94; 77%), heart failure (41/83; 49%), alkalosis (14/35; 40%), hyperkalaemia (42; 37%), acute kidney injury (28; 25%), and hypoxic encephalopathy (23; 20%). |
TextSentencer_T22 |
2084-2175 |
Sentence |
denotes |
Patients with cardiovascular comorbidity were more likely to develop cardiac complications. |
TextSentencer_T23 |
2176-2302 |
Sentence |
denotes |
Regardless of history of cardiovascular disease, acute cardiac injury and heart failure were more common in deceased patients. |
TextSentencer_T24 |
2303-2314 |
Sentence |
denotes |
CONCLUSION: |
TextSentencer_T25 |
2315-2485 |
Sentence |
denotes |
Severe acute respiratory syndrome coronavirus 2 infection can cause both pulmonary and systemic inflammation, leading to multi-organ dysfunction in patients at high risk. |
TextSentencer_T26 |
2486-2671 |
Sentence |
denotes |
Acute respiratory distress syndrome and respiratory failure, sepsis, acute cardiac injury, and heart failure were the most common critical complications during exacerbation of covid-19. |